Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Tax Provisions (2021 - 2025)

Burning Rock Biotech has reported Tax Provisions over the past 5 years, most recently at -$125000.0 for Q4 2025.

  • For Q4 2025, Tax Provisions rose 82.83% year-over-year to -$125000.0; the TTM value through Dec 2025 reached -$220000.0, up 72.77%, while the annual FY2025 figure was $223000.0, 72.33% down from the prior year.
  • Tax Provisions for Q4 2025 was -$125000.0 at Burning Rock Biotech, down from -$30000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $181000.0 in Q4 2021 and troughed at -$728000.0 in Q4 2024.
  • A 5-year average of -$105235.3 and a median of -$61000.0 in 2023 define the central range for Tax Provisions.
  • Biggest five-year swings in Tax Provisions: soared 94.84% in 2022 and later crashed 382.12% in 2024.
  • Year by year, Tax Provisions stood at $181000.0 in 2021, then tumbled by 252.49% to -$276000.0 in 2022, then soared by 45.29% to -$151000.0 in 2023, then crashed by 382.12% to -$728000.0 in 2024, then surged by 82.83% to -$125000.0 in 2025.
  • Business Quant data shows Tax Provisions for BNR at -$125000.0 in Q4 2025, -$30000.0 in Q3 2025, and -$34000.0 in Q2 2025.